ArticleThe journal of allergy and clinical immunology. Global2024
Tolerability and outcomes with rollout of tixagevimab-cilgavimab in patients with common variable immunodeficiency.
Daniela Dluzynski et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.